LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Chemi SpA
03 1Chemino Pharma
04 1Divis Laboratories
05 1Erregierre SpA
06 2Hikal
07 1Jubilant Generics
08 1Jubilant Pharmova
09 1Lupin Ltd
10 1Zhejiang Apeloa Jiayuan Pharmaceutical
11 1Zhejiang Supor Pharmaceuticals Co., LTD
01 2China
02 7India
03 2Italy
04 1U.S.A
01 7Active
02 1Inactive
03 4Blank
01 12Blank
01 12Blank
01 1WC-0030
02 1WC-0092
03 10Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22809
Submission : 2009-05-08
Status : Active
Type : II
NDC Package Code : 12666-0006
Start Marketing Date : 2008-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18922
Submission : 2005-10-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39224
Submission : 2023-12-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38231
Submission : 2023-03-24
Status : Active
Type : II
NDC Package Code : 66651-929
Start Marketing Date : 2023-04-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38384
Submission : 2023-05-29
Status : Active
Type : II
NDC Package Code : 66651-929
Start Marketing Date : 2023-04-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25254
Submission : 2011-08-23
Status : Active
Type : II
NDC Package Code : 14799-2013
Start Marketing Date : 2010-09-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26720
Submission : 2013-03-04
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22419
Submission : 2009-01-21
Status : Inactive
Type : II
Date of Issue : 2022-09-01
Valid Till : 2024-11-04
Written Confirmation Number : WC-0092
Address of the Firm :
NDC Package Code : 65372-1166
Start Marketing Date : 2012-12-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2019-06-17
Valid Till : 2022-06-16
Written Confirmation Number : WC-0030
Address of the Firm :
A Bupropion Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bupropion Hydrobromide, including repackagers and relabelers. The FDA regulates Bupropion Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bupropion Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bupropion Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bupropion Hydrobromide supplier is an individual or a company that provides Bupropion Hydrobromide active pharmaceutical ingredient (API) or Bupropion Hydrobromide finished formulations upon request. The Bupropion Hydrobromide suppliers may include Bupropion Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Bupropion Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 11 companies offering Bupropion Hydrobromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
